Technology
Health
Pharmaceutical
Xeris Pharmaceuticals
$11.969876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$11.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.06 (0.50%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours
Why Robinhood?
You can buy or sell XERS and other stocks, options, ETFs, and crypto commission-free!
About XERS
Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSolâ„¢ and XeriJectâ„¢ formulation technologies. Read More The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Austin, TX.
Employees
90
Headquarters
Chicago, Illinois
Founded
2005
Market Cap
319.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
127.71K
High Today
$12.07
Low Today
$11.57
Open Price
$11.94
Volume
65.43K
52 Week High
$27.98
52 Week Low
$6.85
Collections
Technology
Health
Pharmaceutical
2018 IPO
US
North America
Price Paid on Robinhood
9% Higher
Right Now
52 Week Low
$8.67
Average Price Paid
$10.98
52 Week High
$27.98
XERS Earnings
-$1.07
-$0.95
-$0.83
-$0.71
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.93 per share
Actual
Expected Aug 12, After Hours